MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Aug 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how radiation therapy affects the environment around tumors in patients with locally advanced cervical cancer and pancreatic cancer. The study will collect various samples, like biopsies and blood, as well as treatment-related information before, during, and after patients receive standard radiation treatment. The goal is to better understand how these factors work together and how they might impact treatment outcomes.
To participate in this study, you need to be at least 18 years old and have been diagnosed with locally advanced or metastatic cervical or pancreatic cancer, with plans to receive standard radiation therapy. You also should be in good enough health to manage the procedures involved. If you decide to join, you can expect to provide samples and information that will help researchers learn more about the effects of radiation on cancer. Importantly, this study is currently recruiting participants, so it’s a great time to consider joining if you meet the criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Confirmation of intent to receive radiotherapy for one of the following diagnoses:
- • Cervical cancer
- • Pancreatic cancer
- • ECOG performance status ≤ 2
- • At least 18 years old
- • Able to understand and willing to sign an IRB-approved written informed consent document
- Exclusion Criteria:
- • Any issue (medical, anatomic, other) that might preclude safe acquisition of biospecimens at the discretion of the treating physician
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Cliff Robinson, M.D.
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported